Fairvalue-Calculator Fairvalue-Calculator
EN DE

Guiyang Xintian Pharmaceutical Co (002873) Fair Value & Analysis

Healthcare · CN · Market cap 1.9B CNY

Price¥7.78
Fair Value¥0.8200
Upside-89.5%
Quality95/100
Evidence: High Range ¥0.6200 – ¥1.27

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Guiyang Xintian Pharmaceutical Co (002873) currently trades at ¥7.78, while our model-based Fair Value estimate is ¥0.8200 — implying the stock looks roughly 89.5% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Guiyang Xintian Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of new traditional Chinese medicines in China. The company offers products in various dosage forms, including hard capsules, oral solutions, granules, gels, tablets, syrups, tinctures, lotions, medicated wines, and elixirs. Its products are used for the treatment of gynecological, urinary tract, breast, thyroid, cardiovascular, anti-tumor, and dental diseases, as well as for oral health; and cold, heat-clearing, and blood-tonifying remedies. The company also engages in research and development; consulting; scientific research; accommodation and catering; technology promotion; pharmaceutical research and development; and health food processing activities. Guiyang Xintian Pharmaceutical Co.,Ltd. was founded in 1995 and is based in Guiyang, China.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is Guiyang Xintian Pharmaceutical Co (002873) undervalued?
As of Jun 25, 2026, our model estimates a fair value of ¥0.8200 versus a price of ¥7.78 — about −89% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 002873?
Our 21-model fair value for Guiyang Xintian Pharmaceutical Co is ¥0.8200 (as of Jun 25, 2026), built from audited fundamentals. The current price is ¥7.78.
What is the quality score of 002873?
Guiyang Xintian Pharmaceutical Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.